Thomas Flaten
Stock Analyst at Lake Street
(3.16)
# 1,233
Out of 5,140 analysts
35
Total ratings
40.54%
Success rate
6.05%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $40.98 | +26.89% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $23.03 | +117.11% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.50 | +260.00% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.88 | +131.96% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $4.18 | +163.16% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $47.12 | +48.56% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.87 | +46.56% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.61 | +73.54% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.97 | +75.66% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.61 | +206.51% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $10.92 | +266.30% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.36 | +138.10% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $9.65 | -6.74% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $11.48 | +291.99% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $5.42 | +102.95% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $25.55 | -2.15% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.92 | +156,745.66% | 2 | Nov 17, 2022 |
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $40.98
Upside: +26.89%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $23.03
Upside: +117.11%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.50
Upside: +260.00%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.88
Upside: +131.96%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $4.18
Upside: +163.16%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $47.12
Upside: +48.56%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.87
Upside: +46.56%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.61
Upside: +73.54%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.97
Upside: +75.66%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.61
Upside: +206.51%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $10.92
Upside: +266.30%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.36
Upside: +138.10%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.65
Upside: -6.74%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $11.48
Upside: +291.99%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $5.42
Upside: +102.95%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $25.55
Upside: -2.15%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.92
Upside: +156,745.66%